HIF1A and B-cell non-Hodgkin lymphoma: For instance, the EBV oncoprotein LMP1 can bind to PARP1 and co-activate HIF-1α by the addition of the activating H3K27ac mark to the promoters of HIF-1α target genes, ultimately leading to a glycolytic switch in B cell lymphoma cell-line models [107].